Healthcare & Life Sciences Industry Updates

Google News – Clinical Trials External News

TAGRISSO® (osimertinib) plus savolitinib demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO - Business Wire

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - BioSpace

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials - Nature

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - TradingView

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

How One Woman With a Very Rare Disease Secured a Clinical Trial - The New York Times

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD - Yahoo Finance

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted? - Fierce Biotech

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

August 17, 2026: Registration Open for NIH Collaboratory Virtual Workshop on Endpoint Strategies and Meaningful Outcomes - Rethinking Clinical Trials

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

Sustaining long-term follow-up in cell and gene therapies - clinicaltrialsarena.com

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

WCG Report: Site Delays and Phase II Terminations Rise in 2025 Clinical Trials - The Clinical Trial Vanguard

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

Eli Lily Initiates New Phase III Clinical Trials For Brenipatide In China - TradingView

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

Argenx’s stock rises on Phase III autoimmune myositis victory - clinicaltrialsarena.com

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

WCG Report: Only 11% of Sponsors, CROs Fully Implemented AI in Clinical Trials by Late 2024 - The Clinical Trial Vanguard

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

FDA approves ArkBio’s ziresovir for Phase II trial in severe RSV - clinicaltrialsarena.com

news.google.com · 18 Aug 2026

Google News – Clinical Trials External News

Fate Therapeutics begins Phase II trial of FT819 for lupus nephritis - clinicaltrialsarena.com

news.google.com · 18 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device

Trump nominates policy aide Overton to lead FDA

FDA seeks feedback on generative AI regulations

GE HealthCare names new CFO

TAGRISSO® (osimertinib) plus savolitinib demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO - Business Wire

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - BioSpace

CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials - Nature

Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - TradingView

How One Woman With a Very Rare Disease Secured a Clinical Trial - The New York Times

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD - Yahoo Finance

After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted? - Fierce Biotech

August 17, 2026: Registration Open for NIH Collaboratory Virtual Workshop on Endpoint Strategies and Meaningful Outcomes - Rethinking Clinical Trials

Sustaining long-term follow-up in cell and gene therapies - clinicaltrialsarena.com

WCG Report: Site Delays and Phase II Terminations Rise in 2025 Clinical Trials - The Clinical Trial Vanguard

Eli Lily Initiates New Phase III Clinical Trials For Brenipatide In China - TradingView

Argenx’s stock rises on Phase III autoimmune myositis victory - clinicaltrialsarena.com

WCG Report: Only 11% of Sponsors, CROs Fully Implemented AI in Clinical Trials by Late 2024 - The Clinical Trial Vanguard

FDA approves ArkBio’s ziresovir for Phase II trial in severe RSV - clinicaltrialsarena.com

Fate Therapeutics begins Phase II trial of FT819 for lupus nephritis - clinicaltrialsarena.com